Lycera
  • About Us
  • Scientific Approach
  • News
  • Careers
  • Contact Us
  • Recent News
  • News Archive
Lycera | Pioneers in Autoimmune Treatment

Press Releases

Lycera Announces Key Appointments to Board of Directors
February 15, 2012

Lycera Management to Present at Upcoming Conferences
January 31, 2012

Lycera Achieves First Milestone in Merck Research Collaboration
December 21, 2011

Lycera Appoints Senior Life Sciences Executive Kathleen M. Metters, Ph.D., as President and Chief Executive Officer
October 4, 2011

Lycera Management to Present at Upcoming Conferences
September 7, 2011

U-M spinoff biopharmaceutical company Lycera to move into North Campus Research Complex
June 8, 2011

Lycera Highlights Bioenergetics and RORγt Programs at Industry Conferences
March 27, 2011

Lycera Announces Research Collaboration with Merck to Discover, Develop and Commercialize Drugs for Autoimmune Diseases
March 3, 2011

Data Published in Science Translational Medicine Point to Role of Cellular Bioenergetics as a New Mechanistic Approach to Treat Immune Disorders
January 26, 2011

 

Lycera in the News

Newsmaker: Lycera
August 5, 2011

Merck & Co links up with Lycera in $300 million deal
for autoimmune disease drugs

March 4, 2011

 

Targeting T cell metabolism
March 3, 2011

Lycera snags $307M anti-inflammatory discovery
deal with Merck

March 3, 2011

Lycera Plows Ahead With Drugs To Treat
Autoimmune Disorders

February 24, 2011

 

Lycera